RECKITT BENCKISER GROUP PLC: Completion of Collaboration Agreement

RECKITT BENCKISER GROUP PLC: Completion of Collaboration Agreement
20 May 2013 
 RECKITT BENCKISER ANNOUNCES COMPLETION OF LATAM OTC COLLABORATION AGREEMENT    
                       WITH BRISTOL-MYERS SQUIBB                            
Slough, England - 20 May, 2013 - Reckitt Benckiser Group PLC ("RB") (LSE: RBL)
announces that the three year collaboration agreement signed with Bristol-Myers
Squibb Company (NYSE: BMY) on 10 February 2013 has been completed and that
regulatory approvals, including anti-trust approvals in the relevant
jurisdictions, have now been obtained. 
The terms of the agreement include the transfer of personnel, supply contracts
and an option to acquire legal title to the related intellectual property at
the end of the collaboration period, based on business performance.  Reckitt
Benckiser will account for the transaction as a business combination. 
                                 ENDS                                       
Investor & Analyst Contacts: 
Reckitt Benckiser (RB) 
Richard Joyce 
Director, Investor Relations 
+44 1753 217800 
Media Contacts: 
Reckitt Benckiser (RB) 
Andraea Dawson-Shepherd 
SVP, Global Corporate Communication & Affairs 
+44 1753 446447 
Brunswick (Financial PR) 
David Litterick / Max McGahan 
+44 (0)20 7404 5959 
END 
-0- May/20/2013 06:00 GMT